Epidemiology and Economic Burden of Osteoporosis in Malta

被引:0
|
作者
Ivergard, Moa [1 ]
Svedbom, Axel [1 ]
Hernlund, Emma [1 ]
Compston, Juliet [2 ]
Cooper, Cyrus [3 ,4 ]
Stenmark, Judy [5 ]
McCloskey, Eugene V. [6 ,7 ]
Jonsson, Bengt [8 ]
Galea, Raymond P. [9 ]
Kanis, John A. [7 ,10 ]
机构
[1] OptumInsight, Stockholm, Sweden
[2] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England
[3] Univ Southampton, MRC Lifewurse Epidemiol Unit, Southampton, Hants, England
[4] Univ Oxford, Inst Musculoskeletal Sci, NIHR Musculoskeletal Biomed Res Unit, Oxford, England
[5] Int Osteoporosis Fdn, Nyon, Switzerland
[6] No Gen Hosp, Acad Unit Bone Metab, Sheffield S5 7AU, S Yorkshire, England
[7] Univ Sheffield, WHO Collaborating Ctr Metab Bone Dis, Sheffield S10 2RX, S Yorkshire, England
[8] Stockholm Sch Econ, S-11383 Stockholm, Sweden
[9] Mater Dei Hosp, Dept Obstet & Gynaecol, Msida, Malta
[10] Univ Sheffield, WHO Collaborating Ctr Metab Bone Dis, Sch Med, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This report describes epidemiology, burden, and treatment of osteoporosis in Malta. Introduction Osteoporosis is characterized by reduced bone mass and disruption of bone architecture, resulting in increased risks of fragility fractures which represent the main clinical consequence of the disease. Fragility fractures are associated with substantial pain and suffering, disability and even death for the affected patients and substantial costs to society. The aim of this study is to describe the epidemiology and economic burden of fragility fractures as a consequence of osteoporosis in Malta, as a further detailed addition to the report for the entire European Union (EU27): Osteoporosis in the European Union: Medical Management, Epidemiology and Economic Burden. Methods The literature on fracture incidence and costs of fractures in Malta was reviewed and incorporated into a model estimating the clinical and economic burden of osteoporotic fractures in 2010. Furthermore, data on sales of osteoporosis treatments and the population at high risk were used to estimate treatment uptake and treatment gap. Results It was estimated that approximately 2,600 new fragility fractures were sustained in Malta, comprising 450 hip fractures, 430 vertebral fractures, 470 forearm fractures and 1,300 other fractures (i.e. fractures of the pelvis, rib, humerus, tibia, fibula, clavicle, scapula, sternum and other femoral fractures) in 2010. The economic burden of incident and previous fragility fractures was estimated at (sic) 17 million for the same year. Incident fractures represented 65 % of this cost, long-term fracture care 24 % and pharmacological prevention 12 %. Previous and incident fractures also accounted for 800 quality-adjusted life years (QALYs) lost during 2010. When accounting for the demographic projections for 2025, the number of incident fractures was estimated at 3,800 in 2025, representing an increase of 1,100 fractures. Hip, clinical vertebral (spine), forearm and other fractures were estimated to increase by 230, 190, 140 and 580, respectively. The burden of fractures in Malta in 2025 was estimated to increase by 39 % to (sic) 24 million. Conclusions There is a high cost of osteoporosis with a substantial projected increase of the economic burden driven by aging populations, suggesting that a change in healthcare policy concerning the disease is warranted.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Epidemiology, costs, and the economic burden of fibromyalgia
    Spaeth, Michael
    ARTHRITIS RESEARCH & THERAPY, 2009, 11 (03)
  • [42] Erratum to: Epidemiology, costs, and burden of osteoporosis in Argentina, 2009
    Francisco R. Spivacow
    Ariel Sánchez
    Archives of Osteoporosis, 2010, 5 (1-2) : 7 - 7
  • [43] The burden of osteoporosis in Turkey: a scorecard and economic model
    Rima Aziziyeh
    Javier Garcia Perlaza
    Najma Saleem
    Yeşim Kirazlı
    Elif Akalın
    Rebecca K. McTavish
    Corinne Duperrouzel
    Chris Cameron
    Archives of Osteoporosis, 2020, 15
  • [44] The current economic burden of illness of osteoporosis in Canada
    Hopkins, R. B.
    Burke, N.
    Von Keyserlingk, C.
    Leslie, W. D.
    Morin, S. N.
    Adachi, J. D.
    Papaioannou, A.
    Bessette, L.
    Brown, J. P.
    Pericleous, L.
    Tarride, J.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (10) : 3023 - 3032
  • [45] Economic burden of osteoporosis among women.
    Rousculp, M
    Sasser, A
    Birnbaum, H
    Oster, E
    Lufkin, E
    Mallet, D
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S271 - S271
  • [46] Influence of bisphosphonates on the economic burden of osteoporosis in Iran
    Mirsafa, M.
    Mir, E.
    Tofighi, P.
    Hossein-Nezhad, A.
    Adibi, H.
    Larijani, B.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S149 - S150
  • [47] THE CLINICAL AND ECONOMIC BURDEN OF NONADHERENCE WITH OSTEOPOROSIS MEDICATIONS
    Hiligsmann, M.
    Rabenda, V
    Bruyere, O.
    Reginster, J. Y.
    VALUE IN HEALTH, 2009, 12 (07) : A444 - A444
  • [48] The current economic burden of illness of osteoporosis in Canada
    R. B. Hopkins
    N. Burke
    C. Von Keyserlingk
    W. D. Leslie
    S. N. Morin
    J. D. Adachi
    A. Papaioannou
    L. Bessette
    J. P. Brown
    L. Pericleous
    J. Tarride
    Osteoporosis International, 2016, 27 : 3023 - 3032
  • [49] The burden of osteoporosis in Turkey: a scorecard and economic model
    Aziziyeh, Rima
    Garcia Perlaza, Javier
    Saleem, Najma
    Kirazli, Yesim
    Akalin, Elif
    McTavish, Rebecca K.
    Duperrouzel, Corinne
    Cameron, Chris
    ARCHIVES OF OSTEOPOROSIS, 2020, 15 (01)
  • [50] The epidemiology of CHD in Malta
    Grech, Victor
    Gatt, Miriam
    Calleja, Neville
    CARDIOLOGY IN THE YOUNG, 2024, 34 (03) : 547 - 551